These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
369 related articles for article (PubMed ID: 2993897)
1. Identity of tumour necrosis factor and the macrophage-secreted factor cachectin. Beutler B; Greenwald D; Hulmes JD; Chang M; Pan YC; Mathison J; Ulevitch R; Cerami A Nature; 1985 Aug 8-14; 316(6028):552-4. PubMed ID: 2993897 [TBL] [Abstract][Full Text] [Related]
2. Purification of cachectin, a lipoprotein lipase-suppressing hormone secreted by endotoxin-induced RAW 264.7 cells. Beutler B; Mahoney J; Le Trang N; Pekala P; Cerami A J Exp Med; 1985 May; 161(5):984-95. PubMed ID: 3872925 [TBL] [Abstract][Full Text] [Related]
3. Regulation of lipoprotein lipase synthesis in 3T3-L1 adipocytes by cachectin. Further proof for identity with tumour necrosis factor. Price SR; Olivecrona T; Pekala PH Biochem J; 1986 Dec; 240(2):601-4. PubMed ID: 3814100 [TBL] [Abstract][Full Text] [Related]
4. Cachectin/tumor necrosis factor and interleukin-1 show different modes of combined effect on lipoprotein lipase activity and intracellular lipolysis in 3T3-L1 cells. Ogawa H; Nielsen S; Kawakami M Biochim Biophys Acta; 1989 Jun; 1003(2):131-5. PubMed ID: 2786429 [TBL] [Abstract][Full Text] [Related]
5. Cachectin and tumour necrosis factor as two sides of the same biological coin. Beutler B; Cerami A Nature; 1986 Apr 17-23; 320(6063):584-8. PubMed ID: 3010124 [TBL] [Abstract][Full Text] [Related]
6. Human recombinant TNF suppresses lipoprotein lipase activity and stimulates lipolysis in 3T3-L1 cells. Kawakami M; Murase T; Ogawa H; Ishibashi S; Mori N; Takaku F; Shibata S J Biochem; 1987 Feb; 101(2):331-8. PubMed ID: 3495531 [TBL] [Abstract][Full Text] [Related]
8. Recombinant human cachectin/tumor necrosis factor but not interleukin-1 alpha downregulates lipoprotein lipase gene expression at the transcriptional level in mouse 3T3-L1 adipocytes. Zechner R; Newman TC; Sherry B; Cerami A; Breslow JL Mol Cell Biol; 1988 Jun; 8(6):2394-401. PubMed ID: 3261386 [TBL] [Abstract][Full Text] [Related]
9. Suppression of lipoprotein lipase in 3T3-L1 cells by a mediator produced by SEKI melanoma, a cachexia-inducing human melanoma cell line. Kawakami M; Kondo Y; Imai Y; Hashiguchi M; Ogawa H; Hiragun A; Aotsuka S; Shibata S; Oda T; Murase T J Biochem; 1991 Jan; 109(1):78-82. PubMed ID: 2016276 [TBL] [Abstract][Full Text] [Related]
10. Physiological responses to cachectin. Tracey KJ; Lowry SF; Cerami A Ciba Found Symp; 1987; 131():88-108. PubMed ID: 2836140 [TBL] [Abstract][Full Text] [Related]
11. Cachectin/tumor necrosis factor: production, distribution, and metabolic fate in vivo. Beutler BA; Milsark IW; Cerami A J Immunol; 1985 Dec; 135(6):3972-7. PubMed ID: 2999236 [TBL] [Abstract][Full Text] [Related]
12. Macrophage/monocyte receptor for nonenzymatically glycosylated protein is upregulated by cachectin/tumor necrosis factor. Vlassara H; Moldawer L; Chan B J Clin Invest; 1989 Dec; 84(6):1813-20. PubMed ID: 2556447 [TBL] [Abstract][Full Text] [Related]
13. Bacterial lipopolysaccharide reduces macrophage lipoprotein lipase levels: an effect that is independent of tumor necrosis factor. White JR; Chait A; Klebanoff SJ; Deeb S; Brunzell JD J Lipid Res; 1988 Oct; 29(10):1379-85. PubMed ID: 3235920 [TBL] [Abstract][Full Text] [Related]
14. Recombinant human tumor necrosis factor does not inhibit lipoprotein lipase in primary cultures of isolated human adipocytes. Kern PA J Lipid Res; 1988 Jul; 29(7):909-14. PubMed ID: 3411249 [TBL] [Abstract][Full Text] [Related]
15. Metabolic responses to cachectin/TNF. A brief review. Tracey KJ; Cerami A Ann N Y Acad Sci; 1990; 587():325-31. PubMed ID: 2193578 [TBL] [Abstract][Full Text] [Related]